Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Record identifier

TN_cdi_hal_primary_oai_HAL_hal_03488040v1

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03488040v1

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Full title

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2019, Vol.20 (7), p.998-1010

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03488040v1

Language

English

Formats

Publication information

Publisher

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03488040v1

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03488040v1

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card